Global Plasma Fractionation Competitive Landscape Professional Research Report 2025
Research Summary
Plasma fractionation is a process used in the pharmaceutical and medical industries to separate and purify specific components from blood plasma. Blood plasma is the liquid portion of blood that remains after red and white blood cells and platelets have been removed. Plasma fractionation typically involves a series of steps, including separation, filtration, and purification, to isolate valuable proteins and other components from plasma. These isolated components, such as immunoglobulins, clotting factors, and albumin, are crucial for various medical therapies, including the treatment of immunodeficiency disorders, hemophilia, and other conditions. Plasma fractionation plays a key role in producing a range of therapeutic products derived from human plasma, contributing to advancements in medical treatments and ensuring a safe and reliable supply of plasma-derived medications.
According to DIResearch's in-depth investigation and research, the global Plasma Fractionation market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Plasma Fractionation include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Biological Vaccine, Tiantan Biological, Shuanglin Bio-Pharmacy, Boya Bio-Pharmaceutical, Yuanda Shuyang Pharmaceutical, Weiguang Biological, KM Biologics etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Plasma Fractionation. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Plasma Fractionation market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Plasma Fractionation market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Plasma Fractionation industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Plasma Fractionation Include:
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Biological Vaccine
Tiantan Biological
Shuanglin Bio-Pharmacy
Boya Bio-Pharmaceutical
Yuanda Shuyang Pharmaceutical
Weiguang Biological
KM Biologics
Plasma Fractionation Product Segment Include:
Albumin
Immune Globulin
Coagulation Factor
Others
Plasma Fractionation Product Application Include:
Immunology
Hematology
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Plasma Fractionation Industry PESTEL Analysis
Chapter 3: Global Plasma Fractionation Industry Porter’s Five Forces Analysis
Chapter 4: Global Plasma Fractionation Major Regional Market Size and Forecast Analysis
Chapter 5: Global Plasma Fractionation Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Plasma Fractionation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Plasma Fractionation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Plasma Fractionation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Plasma Fractionation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Plasma Fractionation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Plasma Fractionation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Plasma Fractionation Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 Plasma Fractionation Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Plasma Fractionation Product by Type
- 1.2.1 Albumin
- 1.2.2 Immune Globulin
- 1.2.3 Coagulation Factor
- 1.2.4 Others
- 1.3 Plasma Fractionation Product by Application
- 1.3.1 Immunology
- 1.3.2 Hematology
- 1.3.3 Others
- 1.4 Global Plasma Fractionation Market Size Analysis (2020-2032)
- 1.5 Plasma Fractionation Market Development Status and Trends
- 1.5.1 Plasma Fractionation Industry Development Status Analysis
- 1.5.2 Plasma Fractionation Industry Development Trends Analysis
- 2 Plasma Fractionation Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Plasma Fractionation Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Plasma Fractionation Market Analysis by Regions
- 4.1 Plasma Fractionation Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Plasma Fractionation Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Plasma Fractionation Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Plasma Fractionation Revenue Forecast by Region (2026-2032)
- 5 Global Plasma Fractionation Market Size by Type and Application
- 5.1 Global Plasma Fractionation Market Size by Type (2020-2032)
- 5.2 Global Plasma Fractionation Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Plasma Fractionation Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Plasma Fractionation Market Size by Type
- 6.4 North America Plasma Fractionation Market Size by Application
- 6.5 North America Plasma Fractionation Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Plasma Fractionation Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Plasma Fractionation Market Size by Type
- 7.4 Europe Plasma Fractionation Market Size by Application
- 7.5 Europe Plasma Fractionation Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Plasma Fractionation Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Plasma Fractionation Market Size by Type
- 8.4 China Plasma Fractionation Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Plasma Fractionation Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Plasma Fractionation Market Size by Type
- 9.4 APAC (excl. China) Plasma Fractionation Market Size by Application
- 9.5 APAC (excl. China) Plasma Fractionation Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Plasma Fractionation Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Plasma Fractionation Market Size by Type
- 10.4 Latin America Plasma Fractionation Market Size by Application
- 10.5 Latin America Plasma Fractionation Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Plasma Fractionation Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Plasma Fractionation Market Size by Type
- 11.4 Middle East & Africa Plasma Fractionation Market Size by Application
- 11.5 Middle East & Africa Plasma Fractionation Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Plasma Fractionation Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Plasma Fractionation Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Plasma Fractionation Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Takeda
- 13.1.1 Takeda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Takeda Plasma Fractionation Product Portfolio
- 13.1.3 Takeda Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 CSL
- 13.2.1 CSL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 CSL Plasma Fractionation Product Portfolio
- 13.2.3 CSL Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 Grifols
- 13.3.1 Grifols Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Grifols Plasma Fractionation Product Portfolio
- 13.3.3 Grifols Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 Octapharma
- 13.4.1 Octapharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Octapharma Plasma Fractionation Product Portfolio
- 13.4.3 Octapharma Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 Kedrion
- 13.5.1 Kedrion Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Kedrion Plasma Fractionation Product Portfolio
- 13.5.3 Kedrion Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 LFB Group
- 13.6.1 LFB Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 LFB Group Plasma Fractionation Product Portfolio
- 13.6.3 LFB Group Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 Biotest
- 13.7.1 Biotest Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Biotest Plasma Fractionation Product Portfolio
- 13.7.3 Biotest Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 BPL
- 13.8.1 BPL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 BPL Plasma Fractionation Product Portfolio
- 13.8.3 BPL Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 RAAS
- 13.9.1 RAAS Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 RAAS Plasma Fractionation Product Portfolio
- 13.9.3 RAAS Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 CBPO
- 13.10.1 CBPO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 CBPO Plasma Fractionation Product Portfolio
- 13.10.3 CBPO Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.11 Hualan Biological Vaccine
- 13.11.1 Hualan Biological Vaccine Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Hualan Biological Vaccine Plasma Fractionation Product Portfolio
- 13.11.3 Hualan Biological Vaccine Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.12 Tiantan Biological
- 13.12.1 Tiantan Biological Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 Tiantan Biological Plasma Fractionation Product Portfolio
- 13.12.3 Tiantan Biological Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.13 Shuanglin Bio-Pharmacy
- 13.13.1 Shuanglin Bio-Pharmacy Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.13.2 Shuanglin Bio-Pharmacy Plasma Fractionation Product Portfolio
- 13.13.3 Shuanglin Bio-Pharmacy Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.14 Boya Bio-Pharmaceutical
- 13.14.1 Boya Bio-Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.14.2 Boya Bio-Pharmaceutical Plasma Fractionation Product Portfolio
- 13.14.3 Boya Bio-Pharmaceutical Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.15 Yuanda Shuyang Pharmaceutical
- 13.15.1 Yuanda Shuyang Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.15.2 Yuanda Shuyang Pharmaceutical Plasma Fractionation Product Portfolio
- 13.15.3 Yuanda Shuyang Pharmaceutical Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.16 Weiguang Biological
- 13.16.1 Weiguang Biological Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.16.2 Weiguang Biological Plasma Fractionation Product Portfolio
- 13.16.3 Weiguang Biological Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.17 KM Biologics
- 13.17.1 KM Biologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.17.2 KM Biologics Plasma Fractionation Product Portfolio
- 13.17.3 KM Biologics Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Plasma Fractionation Industry Chain Analysis
- 14.2 Plasma Fractionation Industry Raw Material and Suppliers Analysis
- 14.2.1 Plasma Fractionation Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Plasma Fractionation Typical Downstream Customers
- 14.4 Plasma Fractionation Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook